CSL’s flu vaccine arm Seqirus has assured Australians there will enough flu vaccines to go around, but people may have to wait as the company commits to ramping up production with another 2 million doses.
“We’ve never seen a season where flu vaccination has occurred so early and at such high rates… but what I would say is there will be enough for them, so where you would normally get a vaccine, make an appointment,” Seqirus executive director of commercial operations, Danielle Dowell, said.
“Patients should phone their clinic or pharmacy ahead of time to ensure the vaccines have arrived and are available.”
Seqirus, which is owned by biotechnology giant CSL, produces the flu vaccine for both the southern and northern hemisphere flu seasons. Ms Dowell said the company had put together a global plan to ensure it can supply both markets adequately this year.